Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ankit Javia"'
Autor:
Vivek Patel, Ankit Javia, Rohan Lalani, Sushilkumar Patil, Denish Bardoliwala, Saikat Ghosh, Ambikanandan Misra
Publikováno v:
Therapeutic Delivery. 12:651-670
Background: The current study sought to formulate a dry powder inhalant (DPI) for pulmonary delivery of lipopolymeric nanoparticles (LPNs) consisting of cisplatin and siRNA for multidrug-resistant lung cancer. siRNA against ABCC3 gene was used to sil
Publikováno v:
Therapeutic Delivery. 12:397-418
Despite tremendous research in targeted delivery and specific molecular inhibitors (gene delivery), cytotoxic drug delivery through inhalation has been seen as a core part in the treatment of the lung cancer. Inhalation delivery provides a high dose
Publikováno v:
Colloids and surfaces. B, Biointerfaces. 217
DPK-060 is a synthetic, 17 amino acid peptide, structurally derived from the human protein kininogen. DPK-060 mainly acts by membrane disruption mechanism, thus demonstrating strong broad-spectrum antimicrobial activity against both gram-positive and
Autor:
Vivek, Patel, Denish, Bardoliwala, Rohan, Lalani, Sushilkumar, Patil, Saikat, Ghosh, Ankit, Javia, Ambikanandan, Misra
Publikováno v:
Therapeutic delivery. 12(9)
Autor:
Ankit Javia, Jigar Vanza, Denish Bardoliwala, Saikat Ghosh, Late Ambikanandan Misra, Mrunali Patel, Hetal Thakkar
Publikováno v:
International Journal of Pharmaceutics. 623:121863
Adagen, an enzyme replacement treatment for adenosine deaminase deficiency, was the first protein-polymer conjugate to be approved in early 1990 s. Post this regulatory approval, numerous polymeric drugs and polymeric nanoparticles have entered the m
Autor:
Krutika K. Sawant, Subhas Balaram Bhowmick, Ankit Javia, A. J. Khopade, Shubhadeep Banerjee, Kuntal Maiti, Ambikanandan Misra, Saritha Shetty, Saikat Ghosh, Denish Bardoliwala
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 337
Triple negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC) are amongst the most aggressive forms of solid tumors. TNBC is highlighted by absence of genetic components of progesterone receptor, HER2/neu and estrogen receptor in breast
Autor:
Ambikanandan Misra, Akanksha Patel, Vivek Patel, Ankit Javia, Denish Bardoliwala, Saikat Ghosh
Publikováno v:
Therapeutic Delivery. 10:311-332
Research on siRNA is increasing due to its wide applicability as a therapeutic agent in irreversible medical conditions. siRNA inhibits expression of the specific gene after its delivery from formulation to cytosol region of a cell. RNAi (RNA interfe
Autor:
Jitendra Amrutiya, Pratap Bahadur, Dipesh Baradia, Denish Bardoliwala, Priyanka Bhatt, Subhas Bhowmick, Mahavir B. Chougule, Amit Dabke, Saikat Ghosh, Rahul V. Haware, Nazma Inamdar, Nazma N. Inamdar, Ankit Javia, Nirav Khatri, Atul Kolte, Girish Kore, Arun K. Kotha, Ketan Kuperkar, Manisha S. Lalan, Rohan Lalani, Ashok Mahajan, Pooja Mishra, Ambikanandan Misra, Vishnukant Mourya, Vishnukant K. Mourya, Akanksha Patel, Deepa Patel, Vivek N. Patel, Anjali Pathak, Drashti Pathak, Sushilkumar Patil, Mohan Rathi, Rajan Samant, Aliasgar Shahiwala, Naazneen Surti, Dipali Talele, Hemal Tandel, Sanjay Tiwari, Sonia Trehan, Imran Vhora, Bhavani Prasad Vinjamuri, Chetan Yewale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65f1d1a0b8d31f37a4ea266580f37f8d
https://doi.org/10.1016/b978-0-12-819659-5.00026-4
https://doi.org/10.1016/b978-0-12-819659-5.00026-4
Blood–brain barrier (BBB) provides limits for the transportation of therapeutic agents to the brain. Efforts to directly target the brain by olfactory as well as trigeminal nerve pathway, bypassing BBB, have grown significantly in recent times. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01cf907141f08eb4cd50bc3fd6a71662
https://doi.org/10.1016/b978-0-12-819659-5.00011-2
https://doi.org/10.1016/b978-0-12-819659-5.00011-2
Publikováno v:
Novel Drug Delivery Technologies ISBN: 9789811336416
Parenteral delivery is the second leading drug delivery approach after oral delivery. With the current surge of targeted therapeutic (proteins and peptides) and novel formulation approaches, two major sectors of parenteral controlled drug delivery, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9eb2c0191acdb7ae9693bd8cbe91b8de
https://doi.org/10.1007/978-981-13-3642-3_7
https://doi.org/10.1007/978-981-13-3642-3_7